Detection of signature double‐negative T cells is a predictive marker to identify autoimmune lymphoproliferative syndrome associated with <scp>FAS</scp> loss of function-Reference-Cited by-同舟云学术

Detection of signature double‐negative T cells is a predictive marker to identify autoimmune lymphoproliferative syndrome associated with FAS loss of function

Published:2024-03-14 Issue:5 Volume:99 Page:997-1000
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Eisenhauer Nina¹,Miano Maurizio²^ORCID,Naumann‐Bartsch Nora³,Leyh Jörg³⁴,Dell'Orso Gianluca²,Aigner Michael¹,Fecker Gisela³,Hinze Claas⁵,Wittkowski Helmut⁵,Bruns Heiko¹,Zierk Jakob³^ORCID,Metzler Markus³,Arkwright Peter D.⁶,Graw Frederik¹,Mackensen Andreas¹,Völkl Simon¹^ORCID

Affiliation:

1. Department of Internal Medicine 5, Hematology and Oncology University Hospital Erlangen Erlangen Germany

2. Hematology Unit, Department of Pediatric Hematology/Oncology IRCCS Istituto Giannina Gaslini Genova Italy

3. Department of Pediatrics University Hospital Erlangen Erlangen Germany

4. Department of Pediatric Hematology and Oncology Klinik Hallerwiese‐Cnopfsche Kinderklinik Nürnberg Germany

5. Department of Pediatric Rheumatology and Immunology University Hospital Münster Münster Germany

6. Lydia Becker Institute of Immunology and Inflammation, Royal Manchester Children's Hospital University of Manchester Manchester UK

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.27286

Reference6 articles.

1. Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial

2. Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome

3. Autoimmune‐lymphoproliferative immunodeficiencies (ALPID) a proposed approach to redefining ALPS and other lymphoproliferative immune disorders;Magerus A;J Allergy Clin Immunol,2023

4. FAS‐mediated apoptosis impairment in patients with ALPS/ALPS‐like phenotype carrying variants on CASP10 gene

5. Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome